Description
Buy GLP-1 S helps those works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake. Buy GLP-1 S safety and efficacy were studied in four 68-week trials. Three were randomized, double-blind, placebo-controlled trials (including 16 weeks of dose increases) and one was a double-blind, placebo-controlled, randomized withdrawal trial in which patients receiving GLP-1 S either continued with the treatment or switched to a placebo. More than 2,600 patients received GLP-1 S for up to 68 weeks in these four studies and more than 1,500 patients received placebo.
The largest placebo-controlled trial enrolled adults without diabetes. The average age at the start of the trial was 46 years and 74% of patients were female. The average body weight was 231 pounds (105 kg) and average BMI was 38 kg/m2. Individuals who received GLP-1 S lost an average of 12.4% of their initial body weight compared to individuals who received placebo. Another trial enrolled adults with type 2 diabetes. The average age was 55 years and 51% were female. The average body weight was 220 pounds (100 kg) and average BMI was 36 kg/m2. In this trial, individuals who received GLP-1 S lost 6.2% of their initial body weight compared to those who received placebo.
“For Research Use Only. Not for Human Consumption. 99% Purity.”
Reviews
There are no reviews yet.